Small Cap Hong Kong (HSI) Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Aug 15, 2025

Discover small cap Hong Kong Pharmaceuticals & Biotech companies that are on the HSI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

114 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
1889
Sanai Health Industry Group
HK$0.4319.2%16.0%HK$66.5mn/aPB0.2xn/an/a
8247
Biosino Bio-Technology and Science Incorporation
HK$0.9511.8%61.0%HK$137.5mn/aPB0.8xn/a0%
1312
Kontafarma China Holdings
HK$0.0310%-6.1%HK$173.2mn/aPB0.2xn/a0%
8225
China Health Group
HK$0.185.3%92.5%HK$178.2mn/aPS6.2xn/an/a
1498
PuraPharm
HK$0.461.1%-34.1%HK$179.7mn/aPB1.6xn/a0%
575
Regent Pacific Group
HK$0.86-5.5%91.1%HK$251.0mn/aPS44.6xn/an/a
8158
China Regenerative Medicine International
HK$0.85-5.6%608.3%HK$258.6mn/aPE14.6xn/an/a
1652
Fusen Pharmaceutical
HK$0.359.2%-62.2%HK$262.5mn/aPB0.7xn/a0%
8329
Shenzhen Neptunus Interlong Bio-technique
HK$0.16-0.6%10.3%HK$268.5mn/aPE9.8xn/a3.3%
858
Extrawell Pharmaceutical Holdings
HK$0.137.5%258.3%HK$308.3mn/aPE1.4xn/an/a
897
Wai Yuen Tong Medicine Holdings
HK$0.330%-13.3%HK$365.7mn/aPE51.5xn/a0%
455
Tianda Pharmaceuticals
HK$0.1910.6%-14.5%HK$404.2mn/aPS1.2xn/a0%
1643
Modern Chinese Medicine Group
HK$0.693.0%112.3%HK$496.8mn/aPE47.1xn/a0%
1011
China NT Pharma Group
HK$0.78-1.3%136.4%HK$525.9mn/aPS25.9xn/a0%
3737
Zhongzhi Pharmaceutical Holdings
HK$0.80-7.0%-20.0%HK$690.9mn/aPE6.7xn/a6.2%
6118
Austar Lifesciences
HK$1.354.7%95.7%HK$692.0mn/aPE39.5xn/a0%
239
Pak Fah Yeow International
HK$2.43-2.8%2.1%HK$757.3mn/aPE9.6xn/a8.2%
1228
CANbridge Pharmaceuticals
HK$1.8335.6%617.6%HK$777.5mn/aPS8.4xn/an/a
2197
Clover Biopharmaceuticals
HK$0.6617.9%140.0%HK$856.1mn/aPS20.4xn/an/a
690
Uni-Bio Science Group
HK$0.14-3.3%158.9%HK$865.8mn/aPE10.5xn/a1.9%
2257
Sirnaomics
HK$9.0612.7%131.7%HK$945.4mHK$72.10PS68xS48.0%n/a
2898
Sunho Biologics
HK$6.90-5.2%7.3%HK$1.0bn/aPS25100.4xn/an/a
9939
Kintor Pharmaceutical
HK$2.3614.0%148.4%HK$1.1bn/aPS197xn/an/a
2496
Wuhan YZY Biopharma
HK$5.600%-23.1%HK$1.1bn/aPS9.2xn/an/a
Page 1 of 5